174 related articles for article (PubMed ID: 12754287)
1. Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal-transferase I expression in gastric carcinoma cell lines.
Marcos NT; Cruz A; Silva F; Almeida R; David L; Mandel U; Clausen H; Von Mensdorff-Pouilly S; Reis CA
J Histochem Cytochem; 2003 Jun; 51(6):761-71. PubMed ID: 12754287
[TBL] [Abstract][Full Text] [Related]
2. The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.
Sewell R; Bäckström M; Dalziel M; Gschmeissner S; Karlsson H; Noll T; Gätgens J; Clausen H; Hansson GC; Burchell J; Taylor-Papadimitriou J
J Biol Chem; 2006 Feb; 281(6):3586-94. PubMed ID: 16319059
[TBL] [Abstract][Full Text] [Related]
3. A MUC1 tandem repeat reporter protein produced in CHO-K1 cells has sialylated core 1 O-glycans and becomes more densely glycosylated if coexpressed with polypeptide-GalNAc-T4 transferase.
Olson FJ; Bäckström M; Karlsson H; Burchell J; Hansson GC
Glycobiology; 2005 Feb; 15(2):177-91. PubMed ID: 15456735
[TBL] [Abstract][Full Text] [Related]
4. Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat.
Bennett EP; Hassan H; Mandel U; Mirgorodskaya E; Roepstorff P; Burchell J; Taylor-Papadimitriou J; Hollingsworth MA; Merkx G; van Kessel AG; Eiberg H; Steffensen R; Clausen H
J Biol Chem; 1998 Nov; 273(46):30472-81. PubMed ID: 9804815
[TBL] [Abstract][Full Text] [Related]
5. Changes in the profile of simple mucin-type O-glycans and polypeptide GalNAc-transferases in human testis and testicular neoplasms are associated with germ cell maturation and tumour differentiation.
Rajpert-De Meyts E; Poll SN; Goukasian I; Jeanneau C; Herlihy AS; Bennett EP; Skakkebaek NE; Clausen H; Giwercman A; Mandel U
Virchows Arch; 2007 Oct; 451(4):805-14. PubMed ID: 17694322
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.
Schneider F; Kemmner W; Haensch W; Franke G; Gretschel S; Karsten U; Schlag PM
Cancer Res; 2001 Jun; 61(11):4605-11. PubMed ID: 11389097
[TBL] [Abstract][Full Text] [Related]
7. Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression.
Brockhausen I; Yang J; Lehotay M; Ogata S; Itzkowitz S
Biol Chem; 2001 Feb; 382(2):219-32. PubMed ID: 11308020
[TBL] [Abstract][Full Text] [Related]
8. Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen.
Marcos NT; Pinho S; Grandela C; Cruz A; Samyn-Petit B; Harduin-Lepers A; Almeida R; Silva F; Morais V; Costa J; Kihlberg J; Clausen H; Reis CA
Cancer Res; 2004 Oct; 64(19):7050-7. PubMed ID: 15466199
[TBL] [Abstract][Full Text] [Related]
9. Mucin-type O-glycosylation in Fasciola hepatica: characterisation of carcinoma-associated Tn and sialyl-Tn antigens and evaluation of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity.
Freire T; Casaravilla C; Carmona C; Osinaga E
Int J Parasitol; 2003 Jan; 33(1):47-56. PubMed ID: 12547345
[TBL] [Abstract][Full Text] [Related]
10. Mucin-type O-glycosylation in helminth parasites from major taxonomic groups: evidence for widespread distribution of the Tn antigen (GalNAc-Ser/Thr) and identification of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity.
Casaravilla C; Freire T; Malgor R; Medeiros A; Osinaga E; Carmona C
J Parasitol; 2003 Aug; 89(4):709-14. PubMed ID: 14533679
[TBL] [Abstract][Full Text] [Related]
11. MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase.
Solatycka A; Owczarek T; Piller F; Piller V; Pula B; Wojciech L; Podhorska-Okolow M; Dziegiel P; Ugorski M
Glycobiology; 2012 Aug; 22(8):1042-54. PubMed ID: 22534569
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1.
Ryuko K; Schol DJ; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Karuntu-Wanamarta YA; Verstraeten RA; Miyazaki K; Kenemans P; Hilgers J
Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613
[TBL] [Abstract][Full Text] [Related]
13. Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: GalNAc alpha2,6-sialyltransferase (ST6GalNac I) cDNA.
Julien S; Krzewinski-Recchi MA; Harduin-Lepers A; Gouyer V; Huet G; Le Bourhis X; Delannoy P
Glycoconj J; 2001; 18(11-12):883-93. PubMed ID: 12820722
[TBL] [Abstract][Full Text] [Related]
14. Engineering of N. benthamiana L. plants for production of N-acetylgalactosamine-glycosylated proteins--towards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation.
Daskalova SM; Radder JE; Cichacz ZA; Olsen SH; Tsaprailis G; Mason H; Lopez LC
BMC Biotechnol; 2010 Aug; 10():62. PubMed ID: 20735851
[TBL] [Abstract][Full Text] [Related]
15. Mammalian sialyltransferase ST3Gal-II: its exchange sialylation catalytic properties allow labeling of sialyl residues in mucin-type sialylated glycoproteins and specific gangliosides.
Chandrasekaran EV; Xue J; Xia J; Locke RD; Patil SA; Neelamegham S; Matta KL
Biochemistry; 2011 Nov; 50(44):9475-87. PubMed ID: 21913655
[TBL] [Abstract][Full Text] [Related]
16. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
[TBL] [Abstract][Full Text] [Related]
17. The cell-layer- and cell-type-specific distribution of GalNAc-transferases in the ocular surface epithelia is altered during keratinization.
Argüeso P; Tisdale A; Mandel U; Letko E; Foster CS; Gipson IK
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):86-92. PubMed ID: 12506059
[TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of a new human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, designated pp-GalNAc-T13, that is specifically expressed in neurons and synthesizes GalNAc alpha-serine/threonine antigen.
Zhang Y; Iwasaki H; Wang H; Kudo T; Kalka TB; Hennet T; Kubota T; Cheng L; Inaba N; Gotoh M; Togayachi A; Guo J; Hisatomi H; Nakajima K; Nishihara S; Nakamura M; Marth JD; Narimatsu H
J Biol Chem; 2003 Jan; 278(1):573-84. PubMed ID: 12407114
[TBL] [Abstract][Full Text] [Related]
19. O-Glycosylation and cellular differentiation in a subpopulation of mucin-secreting HT-29 cell line.
Hennebicq-Reig S; Tetaert D; Soudan B; Kim I; Huet G; Briand G; Richet C; Demeyer D; Degand P
Exp Cell Res; 1997 Aug; 235(1):100-7. PubMed ID: 9281357
[TBL] [Abstract][Full Text] [Related]
20. Mucin core O-glycosylation is modulated by neighboring residue glycosylation status. Kinetic modeling of the site-specific glycosylation of the apo-porcine submaxillary mucin tandem repeat by UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases T1 and T2.
Gerken TA; Zhang J; Levine J; Elhammer A
J Biol Chem; 2002 Dec; 277(51):49850-62. PubMed ID: 12397077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
